Markt oder Branche auswählen:
| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | ||
|---|---|---|---|---|---|
| ROCKET PHARMACEUTICALS | 15 | - | -14,45 % | ||
| AUTOLUS THERAPEUTICS | 11 | - | -10,43 % | ||
| ANAPTYSBIO | 7 | 2 | 0,00 % | ||
| HUMACYTE | 6 | 4 | -14,63 % | ||
| WAVE LIFE SCIENCES | 6 | 2 | +8,41 % | ||
| GILEAD SCIENCES | 4 | 5 | +0,32 % | ||
| ARS PHARMACEUTICALS | 4 | - | -5,78 % | ||
| VOR BIOPHARMA | 4 | - | +6,70 % | ||
| ADMA BIOLOGICS | 3 | 4 | +11,58 % | ||
| TERNS PHARMACEUTICALS | 3 | 2 | 0,00 % |
- 24 h
- 7 Tage
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 04:06 | BioCryst 2025 slides: path to $1B revenue, Navenibart expands portfolio | 1 | Investing.com | ||
| 04:06 | Puma Biotechnology Q4 2025 slides: NERLYNX revenue rises 15% sequentially | 1 | Investing.com | ||
| 01:18 | Cathie Wood's ARK sells Nvidia stock, buys Arcturus Therapeutics | 8 | Investing.com | ||
| 00:26 | CytomX Therapeutics (CTMX) Gains Analyst Confidence on Trial Progress | 5 | Insider Monkey | ||
| Fr | Taking a Page From Cancer Drugs, Autoimmune Biotech Alumis Aims for Precision Immunology | 1 | MedCity News | ||
| Fr | Why Lenz Therapeutics Stock Plummeted by Almost 20% This Week | 1 | The Motley Fool | ||
| Fr | William Blair reiterates Autolus stock rating on commercial execution focus | 1 | Investing.com | ||
| Fr | William Blair bestätigt Rating für Autolus: Fokus auf kommerzieller Umsetzung | 2 | Investing.com Deutsch | ||
| Fr | Truist reiterates OmniAb stock Buy rating on biotech recovery | 4 | Investing.com | ||
| Fr | Jefferies senkt Kursziel für Syndax Pharmaceuticals, bestätigt aber Kaufempfehlung | 3 | Investing.com Deutsch | ||
| Fr | 4D Molecular Therapeutics: Jefferies halbiert Kursziel, bestätigt aber Kaufempfehlung | 2 | Investing.com Deutsch | ||
| Fr | BofA raises Rocket Pharmaceuticals price target on execution view | 3 | Investing.com | ||
| Fr | Jefferies cuts Syndax Pharmaceuticals stock price target on valuation | 2 | Investing.com | ||
| Fr | Jefferies cuts 4D Molecular Therapeutics stock price target on valuation | 1 | Investing.com | ||
| Fr | Jefferies lowers Monte Rosa stock price target to $30 on valuation | 1 | Investing.com | ||
| Fr | Humacyte, Inc. - 10-K, Annual Report | 1 | SEC Filings | ||
| Fr | Autolus Therapeutics plc - 10-K, Annual Report | 5 | SEC Filings | ||
| Fr | Kymera Therapeutics, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| Fr | Stoke Therapeutics, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| Fr | Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | 1 | GlobeNewswire (USA) |
1 2 3 4 5 Weiter >>
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.